Skip to main content
PMC home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1997;90(Suppl 31):47–58. doi: 10.1177/014107689709031s10

Management of cystic fibrosis before and after lung transplantation.

J J Egan 1, A A Woodcock 1, A K Webb 1
PMCID: PMC1296099  PMID: 9204012

Full text

PDF
47

Images in this article

54Figure 1
on p.54

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott J., Dodd M., Webb A. K. Different perceptions of disease severity and self care between patients with cystic fibrosis, their close companions, and physician. Thorax. 1995 Jul;50(7):794–796. doi: 10.1136/thx.50.7.794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Armitage J. M., Kormos R. L., Stuart R. S., Fricker F. J., Griffith B. P., Nalesnik M., Hardesty R. L., Dummer J. S. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant. 1991 Nov-Dec;10(6):877–887. [PubMed] [Google Scholar]
  3. Au J., Hawkins T., Venables C., Morritt G., Scott C. D., Gascoigne A. D., Corris P. A., Hilton C. J., Dark J. H. Upper gastrointestinal dysmotility in heart-lung transplant recipients. Ann Thorac Surg. 1993 Jan;55(1):94–97. doi: 10.1016/0003-4975(93)90480-6. [DOI] [PubMed] [Google Scholar]
  4. Barr M. L., Schenkel F. A., Cohen R. G., Chan K. M., Barbers R. G., Marboe C. C., Starnes V. A. Living-related lobar transplantation: recipient outcome and early rejection patterns. Transplant Proc. 1995 Jun;27(3):1995–1996. [PubMed] [Google Scholar]
  5. Bonnefoy-Berard N., Revillard J. P. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3. J Heart Lung Transplant. 1996 May;15(5):435–442. [PubMed] [Google Scholar]
  6. Cooper J. D., Billingham M., Egan T., Hertz M. I., Higenbottam T., Lynch J., Mauer J., Paradis I., Patterson G. A., Smith C. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 1993 Sep-Oct;12(5):713–716. [PubMed] [Google Scholar]
  7. Corey M., McLaughlin F. J., Williams M., Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583–591. doi: 10.1016/0895-4356(88)90063-7. [DOI] [PubMed] [Google Scholar]
  8. Dennis C. M., McNeil K. D., Dunning J., Stewart S., Friend P. J., Alexander G., Higenbottam T. W., Calne R. Y., Wallwork J. Heart-lung-liver transplantation. J Heart Lung Transplant. 1996 May;15(5):536–538. [PubMed] [Google Scholar]
  9. Dennis C., Caine N., Sharples L., Smyth R., Higenbottam T., Stewart S., Wreghitt T., Large S., Wells F. C., Wallwork J. Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant. 1993 Nov-Dec;12(6 Pt 1):893–902. [PubMed] [Google Scholar]
  10. Egan J. J., Barber L., Lomax J., Fox A., Yonan N., Rahman A. N., Campbell C. S., Deiraniya A. K., Carroll K. B., Craske J. Detection of human cytomegalovirus antigenaemia: a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients. Thorax. 1995 Jan;50(1):9–13. doi: 10.1136/thx.50.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Egan J. J., Chadwick P., Lowe L., Woodcock A. A. The potential of nosocomial transmission of Pseudomonas cepacia exists at cardiopulmonary transplant centers. Chest. 1994 May;105(5):1630–1631. doi: 10.1378/chest.105.5.1630d. [DOI] [PubMed] [Google Scholar]
  12. Egan J. J., Hasleton P. S., Yonan N., Rahman A. N., Deiraniya A. K., Carroll K. B., Woodcock A. A. Necrotic, ulcerative bronchitis, the presenting feature of lymphoproliferative disease following heart-lung transplantation. Thorax. 1995 Feb;50(2):205–207. doi: 10.1136/thx.50.2.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Egan J. J., McNeil K., Bookless B., Gould K., Corris P., Higenbottam T., Webb A. K., Woodcock A. A. Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia. Lancet. 1994 Aug 20;344(8921):552–553. doi: 10.1016/s0140-6736(94)91950-x. [DOI] [PubMed] [Google Scholar]
  14. Egan J. J., Webb K., Woodcock A. A. Lung donors for cystic fibrosis patients. Thorax. 1996 Aug;51(8):873–873. doi: 10.1136/thx.51.8.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Egan J., Stewart J., Yonan N., Arrand J., Woodcock A. Non-Hodgkin lymphoma in heart/lung transplant recipients. Lancet. 1994 Feb 19;343(8895):481–481. [PubMed] [Google Scholar]
  16. Elborn J. S., Jagoe T., Shale D. J. Metabolic and respiratory consequences of a glucose load in a hypoxic patient with cystic fibrosis. Ulster Med J. 1992 Oct;61(2):188–192. [PMC free article] [PubMed] [Google Scholar]
  17. Elborn J. S., Shale D. J., Britton J. R. Heart-lung transplantation in cystic fibrosis: predictions for the next decade in England and Wales. Respir Med. 1994 Feb;88(2):135–138. doi: 10.1016/0954-6111(94)90026-4. [DOI] [PubMed] [Google Scholar]
  18. Flume P. A., Egan T. M., Paradowski L. J., Detterbeck F. C., Thompson J. T., Yankaskas J. R. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med. 1994 Jun;149(6):1601–1607. doi: 10.1164/ajrccm.149.6.7516251. [DOI] [PubMed] [Google Scholar]
  19. Gennery A., O'Sullivan J., O'Brien C., Dark J. Which cyclosporin formulation? Lancet. 1996 Oct 26;348(9035):1177–1177. doi: 10.1016/s0140-6736(05)65318-4. [DOI] [PubMed] [Google Scholar]
  20. Halloran P. F. Molecular mechanisms of new immunosuppressants. Clin Transplant. 1996 Feb;10(1 Pt 2):118–123. [PubMed] [Google Scholar]
  21. Hasleton P. S., Woodcock A. A., Yonan N., Deiraniya A. K. Should cryptogenic organizing pneumonia be included in the classification of pulmonary allograft rejection? J Heart Lung Transplant. 1996 Dec;15(12):1268–1269. [PubMed] [Google Scholar]
  22. Herve P., Silbert D., Cerrina J., Simonneau G., Dartevelle P. Impairment of bronchial mucociliary clearance in long-term survivors of heart/lung and double-lung transplantation. The Paris-Sud Lung Transplant Group. Chest. 1993 Jan;103(1):59–63. doi: 10.1378/chest.103.1.59. [DOI] [PubMed] [Google Scholar]
  23. Hodson M. E., Madden B. P., Steven M. H., Tsang V. T., Yacoub M. H. Non-invasive mechanical ventilation for cystic fibrosis patients--a potential bridge to transplantation. Eur Respir J. 1991 May;4(5):524–527. [PubMed] [Google Scholar]
  24. Hosenpud J. D., Novick R. J., Bennett L. E., Keck B. M., Fiol B., Daily O. P. The Registry of the International Society for Heart and Lung Transplantation: thirteenth official report--1996. J Heart Lung Transplant. 1996 Jul;15(7):655–674. [PubMed] [Google Scholar]
  25. Kahan B. D. Cyclosporine. N Engl J Med. 1989 Dec 21;321(25):1725–1738. doi: 10.1056/NEJM198912213212507. [DOI] [PubMed] [Google Scholar]
  26. Koretz R. L. Nutritional supplementation in the ICU. How critical is nutrition for the critically ill? Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):570–573. doi: 10.1164/ajrccm.151.2.7842222. [DOI] [PubMed] [Google Scholar]
  27. Kovarik J. M., Mueller E. A., van Bree J. B., Flückiger S. S., Lange H., Schmidt B., Boesken W. H., Lison A. E., Kutz K. Cyclosporine pharmacokinetics and variability from a microemulsion formulation--a multicenter investigation in kidney transplant patients. Transplantation. 1994 Sep 27;58(6):658–663. [PubMed] [Google Scholar]
  28. Kramer M. R., Denning D. W., Marshall S. E., Ross D. J., Berry G., Lewiston N. J., Stevens D. A., Theodore J. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):552–556. doi: 10.1164/ajrccm/144.3_Pt_1.552. [DOI] [PubMed] [Google Scholar]
  29. Madden B. P., Hodson M. E., Tsang V., Radley-Smith R., Khaghani A., Yacoub M. Y. Intermediate-term results of heart-lung transplantation for cystic fibrosis. Lancet. 1992 Jun 27;339(8809):1583–1587. doi: 10.1016/0140-6736(92)91842-v. [DOI] [PubMed] [Google Scholar]
  30. Matesanz R., Miranda B., Felipe C. Organ procurement in Spain: impact of transplant coordination. Clin Transplant. 1994 Jun;8(3 Pt 1):281–286. [PubMed] [Google Scholar]
  31. Naon H., Hack S., Shelton M. T., Gotthoffer R. C., Gozal D. Resting energy expenditure. Evolution during antibiotic treatment for pulmonary exacerbation in cystic fibrosis. Chest. 1993 Jun;103(6):1819–1825. doi: 10.1378/chest.103.6.1819. [DOI] [PubMed] [Google Scholar]
  32. Nelson J. W., Butler S. L., Krieg D., Govan J. R. Virulence factors of Burkholderia cepacia. FEMS Immunol Med Microbiol. 1994 Feb;8(2):89–97. doi: 10.1111/j.1574-695X.1994.tb00430.x. [DOI] [PubMed] [Google Scholar]
  33. Norman D. J., Shield C. F., 3rd, Henell K. R., Kimball J., Barry J. M., Bennett W. M., Leone M. Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection. Transplantation. 1988 Oct;46(4):523–529. doi: 10.1097/00007890-198810000-00011. [DOI] [PubMed] [Google Scholar]
  34. Opelz G., Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993 Dec 18;342(8886-8887):1514–1516. doi: 10.1016/s0140-6736(05)80084-4. [DOI] [PubMed] [Google Scholar]
  35. Patterson G. M., Wilson S., Whang J. L., Harvey J., Agacki K., Patel H., Theodore J. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. J Heart Lung Transplant. 1996 Feb;15(2):175–181. [PubMed] [Google Scholar]
  36. Piper A. J., Parker S., Torzillo P. J., Sullivan C. E., Bye P. T. Nocturnal nasal IPPV stabilizes patients with cystic fibrosis and hypercapnic respiratory failure. Chest. 1992 Sep;102(3):846–850. doi: 10.1378/chest.102.3.846. [DOI] [PubMed] [Google Scholar]
  37. Ramirez J. C., Patterson G. A., Winton T. L., de Hoyos A. L., Miller J. D., Maurer J. R. Bilateral lung transplantation for cystic fibrosis. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg. 1992 Feb;103(2):287–294. [PubMed] [Google Scholar]
  38. Ryan P. J., Stableforth D. E. Referral for lung transplantation: experience of a Birmingham Adult Cystic Fibrosis Centre between 1987 and 1994. Thorax. 1996 Mar;51(3):302–305. doi: 10.1136/thx.51.3.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Shaw D., Poxton I. R., Govan J. R. Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol Med Microbiol. 1995 Apr;11(2):99–106. doi: 10.1111/j.1574-695X.1995.tb00095.x. [DOI] [PubMed] [Google Scholar]
  40. Snell G. I., de Hoyos A., Krajden M., Winton T., Maurer J. R. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest. 1993 Feb;103(2):466–471. doi: 10.1378/chest.103.2.466. [DOI] [PubMed] [Google Scholar]
  41. Stead R. J., Davidson T. I., Duncan F. R., Hodson M. E., Batten J. C. Use of a totally implantable system for venous access in cystic fibrosis. Thorax. 1987 Feb;42(2):149–150. doi: 10.1136/thx.42.2.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tazelaar H. D., Baird A. M., Mill M., Grimes M. M., Schulman L. L., Smith C. R. Bronchocentric mycosis occurring in transplant recipients. Chest. 1989 Jul;96(1):92–95. doi: 10.1378/chest.96.1.92. [DOI] [PubMed] [Google Scholar]
  43. Trulock E. P., Ettinger N. A., Brunt E. M., Pasque M. K., Kaiser L. R., Cooper J. D. The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures. Chest. 1992 Oct;102(4):1049–1054. doi: 10.1378/chest.102.4.1049. [DOI] [PubMed] [Google Scholar]
  44. Wight C., Cohen B. Shortage of organs for transplantation. BMJ. 1996 Apr 20;312(7037):989–990. doi: 10.1136/bmj.312.7037.989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Yacoub M. H., Banner N. R., Khaghani A., Fitzgerald M., Madden B., Tsang V., Radley-Smith R., Hodson M. Heart-lung transplantation for cystic fibrosis and subsequent domino heart transplantation. J Heart Transplant. 1990 Sep-Oct;9(5):459–467. [PubMed] [Google Scholar]
  46. Yamagishi Y., Fujita J., Takigawa K., Negayama K., Nakazawa T., Takahara J. Clinical features of Pseudomonas cepacia pneumonia in an epidemic among immunocompromised patients. Chest. 1993 Jun;103(6):1706–1709. doi: 10.1378/chest.103.6.1706. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES